The estimated market size of the Global Hyperimmune Globulins is expected to reach USD billion in revenue, with a significant Compound Annual Growth Rate (CAGR) of anticipated through 2027. The surge in global deadly disease outbreaks is a primary driver of market growth. Hyperimmune globulins, utilized to treat active infections in immunosuppressed hosts, resemble Intravenous Immunoglobulins...